Archana Ajmera, MSN, ANP-BC, AOCNP is a board-certified adult nurse practitioner and advanced oncology-certified nurse practitioner at US San Diego Health. She cares for patients with prostate cancer, renal cell carcinoma, urothelial carcinoma, testicular germ cell tumors and penile carcinoma, and has expertise in chemotherapy, immunotherapy, targeted therapy, and investigational agents. She plays an active role in clinical research by serving as a sub-investigator and serves as the genitourinary oncology board member for the Alliance Oncology Nursing Committee. In addition to her clinical role, Ajmera is a strong advocate for advanced APP (Advanced Practice Provider) practice and is the APP Supervisor for the Division of Hematology Oncology.
Prior to joining UC San Diego Health, Ajmera was an oncology nurse practitioner at UC San Francisco, where she cared for adults with hematologic malignancies and bone marrow transplant candidates, as well as women receiving breast cancer treatment. She was also an oncology nurse practitioner at Massachusetts General Hospital in Boston, where she managed the care of women undergoing treatment with surgery and chemotherapy for gynecologic malignancies.
Ajmera earned her master's degree in nursing from MGH Institute of Health Professions School of Nursing in Boston and earned her bachelor's degree in nutritional sciences from UC Berkeley. She is a member of the American Society of Clinical Oncology, Alliance Clinical Trials Network, Advanced Practice Society for Hematology and Oncology, and National Comprehensive Cancer Network.
Pedro C. Barata, MD, MSc, FACP is the director of Clinical Genitourinary Medical Oncology Research Program at University Hospitals Siedman Cancer Center and associate professor of Medicine at Case Western University in Cleveland, Ohio. He is co-leader of the Genitourinary Disease Team, a medical oncologist, and a renowned clinical trialist. His research interests include experimental therapeutics and molecular profiling of tumors and genomic-based therapies for genitourinary tumors, while his clinical interests include kidney, prostate, and bladder cancers.
Dr. Barata is an active member in numerous professional committees and societies, including the American Urological Association, the American Society of Clinical Oncology, the American Association for Cancer Research, and the Society for Immunotherapy of Cancer. He is the recipient of numerous research and educational grants and has authored and co-authored dozens of publications.
Dr. Barata is American board-certified in Medical Oncology and Internal Medicine. He completed his clinical fellowship in experimental therapeutics in genitourinary tumors at the Cleveland Clinic Taussig Cancer Center in Cleveland, Ohio. During that time, he also rotated at the phase I / Experimental Therapeutics Department at MD Anderson Cancer Center, Houston, Texas. He completed his fellowship in medical oncology at Alameda Santo Dos Capuchos in Portugal, and his medical degree at the University of Lisbon.
Kimberly King-Spohn is the director of genetic counseling at Wellstar Health System’s Wellstar Cancer Program in Marietta, Georgia. She is a board-certified genetic counselor and led the creation and development of the hereditary cancer risk assessment program at WellStar. She also serves as an adjunct professor for the Emory University Genetic Counseling Training program where she has lectured on hereditary colon cancer syndromes since the inception of the program in 2013.
King-Spohn previously served as the coordinator of Genetics Services at the Family Health Council of Central Pennsylvania. She coordinated grants for the state’s Department of Health to provide genetics services through Women’s Health centers within the state. She has served as the inaugural chair of the Georgia Cancer Genetics Network, has been awarded the National Society of Genetic Counselors Abstract of the Year Award and has presented numerous abstracts at professional conferences.
King-Spohn earned her master’s degree in genetic counseling from Arcadia University and her bachelor’s degree from Penn State University. She is board certified and licensed to provide genetic counseling in the state of Georgia.